<DOC>
	<DOCNO>NCT00237393</DOCNO>
	<brief_summary>The purpose study determine quetiapine effective treatment PTSD .</brief_summary>
	<brief_title>Quetiapine Treatment Post-Traumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description>Objective : To assess impact quetiapine core PTSD symptom associate psychiatric comorbidity include depressive positive negative psychotic symptom . Research Design : 12-week , double-blind , placebo-controlled , randomize , fixed-flexible dose trial quetiapine monotherapy . Intervention : Eligible patient randomize receive quetiapine start 25 mg daily match placebo . Dose adjustment ( minimum 50 mg maximum 800 mg ) , make investigator 's discretion accord patient 's clinical response .</detailed_description>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Male female patient 18 year age old ethnic background meeting Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) criterion PTSD . Score least 50 CAPSSX baseline . Competent give inform consent . If female , patient use medically approve contraceptive , otherwise childbearing potential . Patients take medication herbal remedy psychiatric indication within one week prior randomized phase . Other medication , , must keep stable least one month prior randomization . History sensitivity quetiapine Use antipsychotic , antidepressant , benzodiazepine ( except shortterm use study specify Concomitant Medications section ) within one week prior randomization throughout study period . Medical condition may prevent safe administration quetiapine include clinically significant hepatic , cardiac , pulmonary disease . Medical disorder may cause exacerbate anxiety symptom . Alcohol drug abuse dependence within one month study entry define DSMIV criterion . Schizophrenia , schizoaffective disorder , bipolar disorder . Suicidal homicidal ideation clinically significant dangerousness Currently seek compensation increase compensation effect trauma . Initiation change psychotherapy within 3 month randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Posttraumatic stress disorder</keyword>
	<keyword>Treatment</keyword>
	<keyword>Quetiapine</keyword>
</DOC>